For example, results of this study allow us to better understand a complex interaction of FVIII and LRP1 (Chun et al, under preparation), which can facilitate generation of longer-acting therapeutic FVIII for treatment of Hemophilia A. Future studies will investigate this mechanism in relation to other ligands of the LDLR family receptors. This evidence concerns the gene LDLR and hemophilia A.